The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex
Abstract
Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes. Akt/PKB activation requires the phosphorylation of Thr 308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser 473 within the carboxyl-terminal hydrophobic motif by an unknown kinase. We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its associated protein rictor are necessary for Ser 473 phosphorylation and that a reduction in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector. The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser 473 in vitro and facilitated Thr 308 phosphorylation by PDK1. Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Akt is also phosphorylated within the carboxyl-terminal hydrophobic motif at Ser473 by the serine/threonine kinase mammalian target of rapamycin complex 2 (mTORC2), within a rapamycin-insensitive protein complex (27).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [27]
Citations
Cites
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Self-citationMechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Self-citationLoewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Sujuti, H., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,130
Self-citationThe TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Толкачева, Т. А., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Stephens, L., Anderson, K. E., Stokoe, D., Erdjument‐Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., McCormick, F. P., Tempst, P., et al. (1998) · Science · doi:10.1126/science.279.5351.710 · Cited by 1,061
Research works printed but not linked: 1
- A. L. Edinger, C. M. Linardic, G. G. Chiang, C. B. Thompson, R. T. Abraham, Cancer Res.63, 8451 (2003).
Cited by
Sorted by citations
Items 501–600 of 1,075
PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer
Mulholland, D. J., Dedhar, S., Wu, H., & Nelson, C. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209020 · Cited by 218
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
Kumar, A. T., Harris, T. E., Keller, S. R., Choi, K. M., Magnuson, M. A., & Lawrence, J. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01405-07 · Cited by 223
Cholesterol trafficking is required for mTOR activation in endothelial cells
Xu, J., Dang, Y., Ren, Y. R., & Liu, J. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910872107 · Cited by 209
Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders
Ehninger, D., & Silva, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.002 · Cited by 223
Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
Liu, Q., Xu, C., Kirubakaran, S., Zhang, X., Hur, W., Liu, Y., Kwiatkowski, N. P., Wang, J., Westover, K. D., Gao, P., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1702 · Cited by 219
Self-citationFox, D. B., Garcia, N. M. G., McKinney, B. J., Lupo, R., Noteware, L. C., Newcomb, R., Liu, J., Locasale, J. W., Hirschey, M. D., & Alvarez, J. V. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0191-z · Cited by 214
CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
Burkhardt, L., Fuchs, S., Krohn, A., Masser, S., Mäder, M., Kluth, M., Bachmann, F., Huland, H., Steuber, T. P., Graefen, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1342 · Cited by 218
MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells
Jones, R. G., & Pearce, E. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.028 · Cited by 218
Regulation of mTORC2 Signaling
Fu, W., & Hall, M. N. (2020) · Genes · doi:10.3390/genes11091045 · Cited by 225
The amino acid sensitive TOR pathway from yeast to mammals
Dann, S. G., & Thomas, G. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.068 · Cited by 216
mTORC2 Regulates Neutrophil Chemotaxis in a cAMP- and RhoA-Dependent Fashion
Liu, L., Das, S., Losert, W., & Parent, C. A. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.11.004 · Cited by 208
Matsuo, T., Otsubo, Y., Urano, J., Tamanoi, F., & Yamamoto, M. P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01039-06 · Cited by 212
The Insulin-Like Growth Factor System in Cancer
Weroha, S. J., & Haluska, P. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.014 · Cited by 213
Pungsrinont, T., Kallenbach, J., & Baniahmad, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011088 · Cited by 218
Recent advances and limitations of mTOR inhibitors in the treatment of cancer
Ali, E. S., Mitra, K., Akter, S., Ramproshad, S., Mondal, B., Khan, I. N., Islam, M. T., Sharifi‐Rad, J., Călina, D. C., & Cho, W. C. S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02706-8 · Cited by 228
Wang, C., Mao, X., Wang, L., Liu, M., Wetzel, M. D., Guan, K.-L., Dong, L. Q., & Liu, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700098200 · Cited by 210
Intracellular signaling pathway regulation of myelination and remyelination in the CNS
Gaesser, J. M., & Fyffe-Maricich, S. L. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.008 · Cited by 217
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
Involvement of Akt in neurite outgrowth
Read, D. E., & Gorman, A. M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0057-8 · Cited by 213
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
Zhou, Q., Lui, V. W. Y., & Yeo, W. (2011) · Future Oncology · doi:10.2217/fon.11.95 · Cited by 217
Gu, Y., de Albuquerque, C. P., Braas, D., Zhang, W., Villa, G. R., Bi, J., Ikegami, S., Masui, K., Gini, B., Yang, H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.030 · Cited by 208
Hurov, K. E., Cotta-Ramusino, C., & Elledge, S. J. (2010) · Genes & Development · doi:10.1101/gad.1934210 · Cited by 210
Rachdi, L., Balcázar, N., Osorio-Duque, F., Elghazi, L., Weiss, A., Gould, A. P., Chang-Chen, K. J., Gambello, M. J., & Bernal‐Mizrachi, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803047105 · Cited by 217
Gibbons, J. J., Abraham, R. T., & Yu, K. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.10.011 · Cited by 212
Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate
Gan, X., Wang, J., Su, B., & Wu, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195016 · Cited by 217
Ma, Y., Su, Q., Yue, C., Zou, H., Zhu, J., Zhao, H., Song, R., & Liu, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113491 · Cited by 214
PIKKing on PKB: regulation of PKB activity by phosphorylation
Bozulic, L., & Hemmings, B. A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.02.002 · Cited by 208
Karali, E., Bellou, S., Stellas, D., Klinakis, A., Murphy, C., & Fotsis, T. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.022 · Cited by 214
Localization of mTORC2 activity inside cells
Ebner, M., Sinkovics, B., Szczygieł, M., Ribeiro, D. W., & Yudushkin, I. A. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201610060 · Cited by 214
Sánchez-Gurmaches, J., Tang, Y., Jespersen, N. Z., Wallace, M., Calejman, C. M., Gujja, S., Li, H., Edwards, Y. J. K., Wolfrum, C., Metallo, C. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.008 · Cited by 204
Self-citationThe Alzheimer's disease mitochondrial cascade hypothesis: an update
Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206
Yu, K., Shi, C., Toral‐Barza, L., Lucas, J., Shor, B., Kim, J. E., Zhang, W., Mahoney, R., Gaydos, C., Tardio, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2340 · Cited by 214
(2010) · doi:10.1074/jbc.m110.168039 · Cited by 207
PIM kinase (and Akt) biology and signaling in tumors
Warfel, N. A., & Kraft, A. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.001 · Cited by 209
PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors
Meric‐Bernstam, F., Akçakanat, A., Chen, H., Do, K.-A., Sangai, T., Adkins, F. C., Gonzalez-Angulo, A. M., Rashid, A., Crosby, K., Dong, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2123 · Cited by 212
Rojo, F., Nájera, L., Lirola, J. L., Jimenez, J., Guzmán, M., Sabadell, M. D., Baselga, J. M., & y Cajal, S. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1560 · Cited by 207
Research progress of mTOR inhibitors
Chen, Y., & Zhou, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112820 · Cited by 219
Beyond ATM: The protein kinase landscape of the DNA damage response
Bensimon, A., Aebersold, R. H., & Shiloh, Y. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.013 · Cited by 214
Budanov, A. V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3530 · Cited by 208
TOR regulation of AGC kinases in yeast and mammals
Jacinto, E., & Lorberg, A. (2008) · Biochemical Journal · doi:10.1042/bj20071518 · Cited by 203
The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid
Lee, H.-K., Kumar, P., Fu, Q., Rosen, K. M., & Querfurth, H. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0777 · Cited by 185
Leiria, L. O., Wang, C., Lynes, M. D., Yang, K., Shamsi, F., Sato, M. M., Sugimoto, S., Chen, E. Y.-S., Bussberg, V., Narain, N. R., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.001 · Cited by 205
mTOR-Dependent Cell Survival MechanismsPreprint
Hung, C., García-Haro, L., Sparks, C. A., & Guertin, D. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008771 · Cited by 215
Self-citationSirolimus Reduces Polycystic Liver Volume in ADPKD Patients
Qian, Q., Du, H., King, B. F., Kumar, S., Dean, P. G., Cosio, F. G., & Torres, V. E. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050626 · Cited by 203
Human Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes
Albers, P. H., Pedersen, A. J. T., Birk, J. B., Steenberg, D. E., Vind, B. F., Baba, O., Nøhr, J., Højlund, K., & Wojtaszewski, J. F. P. (2014) · Diabetes · doi:10.2337/db14-0590 · Cited by 207
Kumar, M., & Bansal, N. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02611-7 · Cited by 208
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
Xie, Y., Shi, X., Sheng, K., Han, G., Li, W., Zhao, Q., Jiang, B., Feng, J., Li, J., & Gu, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9713 · Cited by 505
Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
Beevers, C. S., Chen, L., Liu, L., Luo, Y., Webster, N. J. G., & Huang, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2367 · Cited by 208
de Theije, C. G. M., Wu, J., da Silva, S. L., Kamphuis, P. J. G. H., Garssen, J., Korte, S. M., & Kraneveld, A. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.013 · Cited by 212
Woo, S.-Y., Kim, D., Jun, C., Kim, Y. M., Haar, E. V., Lee, S.-I., Hegg, J. W., Bandhakavi, S., Griffin, T. J., & Kim, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704343200 · Cited by 206
Building mammalian signalling pathways with RNAi screens
Moffat, J., & Sabatini, D. M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1860 · Cited by 204
Self-citationOverview of current targeted therapy in gallbladder cancer
Song, X., Hu, Y., Li, Y., Shao, R., Liu, F., & Liu, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00324-2 · Cited by 208
Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis
Nassour, J., Aguiar, L. G., Correia, A., Schmidt, T. T., Mainz, L., Przetocka, S., Haggblom, C., Tadepalle, N., Williams, A. E., Shokhirev, M. N., et al. (2023) · Nature · doi:10.1038/s41586-023-05710-8 · Cited by 210
Wang, S., Xia, P., Ye, B., Huang, G., Liu, J., & Fan, Z. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.10.005 · Cited by 209
PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
Willems, L., Tamburini, J., Chapuis, N., Lacombe, C., Mayeux, P., & Bouscary, D. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0227-y · Cited by 208
Klos, K. S., Wyszomierski, S. L., Sun, M., Tan, M., Zhou, X., Li, P., Yang, W., Yin, G., Hittelman, W. N., & Yu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4559 · Cited by 201
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Frost, R. A., & Lang, C. H. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00089.2007 · Cited by 200
Macropinocytosis confers resistance to therapies targeting cancer anabolism
Jayashankar, V., & Edinger, A. L. (2020) · Nature Communications · doi:10.1038/s41467-020-14928-3 · Cited by 200
Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
Maiese, K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12804 · Cited by 202
Fine tuning the immune response with PI3K
Fruman, D. A., & Bismuth, G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00750.x · Cited by 207
Mitochondria Associated Membranes (MAMs): Architecture and physiopathological role
Barazzuol, L., Giamogante, F., & Calí, T. (2021) · Cell Calcium · doi:10.1016/j.ceca.2020.102343 · Cited by 213
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 247
Moorman, N. J., Cristea, I. M., Terhune, S. S., Rout, M. P., Chait, B. T., & Shenk, T. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.002 · Cited by 194
Green, A. S., Chapuis, N., Trovati Maciel, T., Willems, L., Lambert, M., Arnoult, C., Boyer, O., Bardet, V., Park, S., Foretz, M., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269837 · Cited by 199
The role of autophagy in tumour development and cancer therapy
Rosenfeldt, M. T., & Ryan, K. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001306 · Cited by 203
Bhagwat, S. V., Gokhale, P. C., Crew, A. P. A., Cooke, A., Yao, Y., Mantis, C., Kahler, J., Workman, J. E., Bittner, M., Dudkin, L., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1099 · Cited by 203
Kawazu, M., Saso, K., Tong, K. I., McQuire, T., Goto, K., Son, D.-O., Wakeham, A. C., Miyagishi, M., Mak, T. W., & Okada, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017830 · Cited by 201
The secret life of kinases: functions beyond catalysis
Rauch, J., Volinsky, N., Romano, D., & Kölch, W. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-23 · Cited by 209
Walters, B. J., Mercaldo, V., Gillon, C. J., Yip, M., Neve, R. L., Boyce, F. M., Frankland, P. W., & Josselyn, S. A. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.31 · Cited by 197
Fang, Z., Grütter, C., & Rauh, D. (2013) · ACS Chemical Biology · doi:10.1021/cb300663j · Cited by 197
Spangle, J. M., & Münger, K. (2010) · Journal of Virology · doi:10.1128/jvi.00974-10 · Cited by 204
Vega, F., Medeiros, L. J., Leventaki, V., Atwell, C., Cho‐Vega, J. H., Tian, L., Claret, F.-X., & Rassidakis, G. Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3018 · Cited by 194
TOR Complex 2 Integrates Cell Movement during Chemotaxis and Signal Relay in Dictyostelium
Lee, S. D., Comer, F. I., Sasaki, A. T., McLeod, I. X., Duong, Y., Okumura, K., Yates, J. R., Parent, C. A., & Firtel, R. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-04-0342 · Cited by 191
PDK1: At the crossroad of cancer signaling pathways
Gagliardi, P. A., Puliafito, A., & Primo, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.014 · Cited by 196
Araki, K., & Miyoshi, Y. (2017) · Breast Cancer · doi:10.1007/s12282-017-0812-x · Cited by 201
Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway
Yoshida, H., Ishii, M., & Akagawa, M. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.07.022 · Cited by 206
Regulation of mRNA Translation by Signaling PathwaysPreprint
Roux, P. P., & Topisirovic, I. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012252 · Cited by 206
Amino Acids Activate Mammalian Target of Rapamycin Complex 2 (mTORC2) via PI3K/Akt Signaling
Tato, I., Bartrons, R., Ventura, F., & Rosa, J. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166991 · Cited by 201
Yue, B., Cai, D., Liu, C., Fang, C., & Yan, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.180 · Cited by 195
The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex
Heikamp, E., Patel, C. H., Collins, S., Waickman, A. T., Oh, M. H., Sun, I., Illei, P. B., Sharma, A., Náray‐Fejes‐Tóth, A., Fejes‐Tóth, G., et al. (2014) · Nature Immunology · doi:10.1038/ni.2867 · Cited by 198
Wang, G., Barrett, J. W., Stanford, M. M., Werden, S. J., Johnston, J. B., Gao, X., Sun, M., Cheng, J. Q., & McFadden, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509341103 · Cited by 194
Complexity of the TOR signaling network
Inoki, K., & Guan, K. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.02.002 · Cited by 191
Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation
Ishiuchi, S., Yoshida, Y., Sugawara, K., Aihara, M., Ohtani, T., Watanabe, T., Saito, N., Tsuzuki, K., Okado, H., Miwa, A., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2180-07.2007 · Cited by 193
Birket, M. J., Ribeiro, M. C., Kosmidis, G., Ward, D., Leitoguinho, A. R., van de Pol, V., Dambrot, C., Devalla, H. D., Davis, R. P., Mastroberardino, P. G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.025 · Cited by 203
Diz-Muñoz, A., Thurley, K., Chintamen, S., Altschuler, S. J., Wu, L. F., Fletcher, D. A., & Weiner, O. D. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002474 · Cited by 187
Singh, A. K., Kashyap, M. P., Tripathi, V., Singh, S., Garg, G., & Rizvi, S. I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0129-3 · Cited by 196
Wang, C., Wang, H., Zhang, D., Luo, W., Liu, R., Xu, D., Diao, L., Liao, L., & Liu, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-05449-1 · Cited by 192
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Leiphrakpam, P., & Are, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063178 · Cited by 193
Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation
Foster, K. G., Acosta-Jaquez, H. A., Roméo, Y., Üstünel, B. E., Soliman, G. A., Carriere, A., Roux, P. P., Ballif, B. A., & Fingar, D. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029637 · Cited by 197
Vincent, E. E., Elder, D. J. E., Thomas, E. C., Phillips, L. D., Morgan, C., Pawade, J., Sohail, M., May, M., Hetzel, M. R., & Tavaré, J. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.132 · Cited by 205
Cho, D. C., Cohen, M. B., Panka, D. J., Collins, M. P., Ghebremichael, M. S., Atkins, M. B., Signoretti, S., & Mier, J. W. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3022 · Cited by 192
Multiple signaling pathways promote B lymphocyte stimulator–dependent B-cell growth and survival
Woodland, R. T., Fox, C. J., Schmidt, M. R., Hammerman, P. S., Opferman, J. T., Korsmeyer, S. J., Hilbert, D. M., & Thompson, C. B. (2007) · Blood · doi:10.1182/blood-2007-03-077222 · Cited by 199
Localization of Rheb to the endomembrane is critical for its signaling function
Buerger, C., DeVries, B., & Stambolic, V. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.220 · Cited by 192
The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
Dobbin, Z. C., & Landen, C. N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14048213 · Cited by 195
mTOR signaling in glioblastoma: lessons learned from bench to bedside
Akhavan, D., Cloughesy, T. F., & Mischel, P. S. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq052 · Cited by 195
Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802537200 · Cited by 197
Ursolic acid, a potential anticancer compound for breast cancer therapy
Yin, R., Li, T., Tian, J., Xi, P., & Liu, R. H. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1203755 · Cited by 191
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Ardestani, A. D., Lupše, B., Kido, Y., Leibowitz, G., & Maedler, K. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.004 · Cited by 198
Barlow, A. D., Nicholson, M. L., & Herbert, T. P. (2013) · Diabetes · doi:10.2337/db13-0106 · Cited by 194
Metadata
- Authors
- Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Guertin, David A.
- Ali, Siraj M.
- Sabatini, David M.
- Venue
- Science
- Published
- 2005-02-18
- Volume
- 307
- Issue
- 5712
- Pages
- 1098-1101
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4238567307
- Cited by
- 6,216
- References
- 28
- Citations by year
- 2026: 119 · 2025: 176 · 2024: 229 · 2023: 275 · 2022: 254 · 2021: 323 · 2020: 324 · 2019: 318 · 2018: 350 · 2017: 329 · 2016: 303 · 2015: 396 · 2014: 358 · 2013: 386 · 2012: 378
- FWCI
- 86.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI47389, R01AI047389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Akt/protein kinase B, Rictor, mTOR, TOR signaling, Ser473 phosphorylation, PDPK1, kinase regulation, PTEN, cancer, therapeutic target, Drosophila
- MeSH terms
- Regulatory-Associated Protein of mTOR, Rapamycin-Insensitive Companion of mTOR Protein, Animals, Carrier Proteins, Cell Line, Drosophila melanogaster, Enzyme Activation, Humans, Phosphorylation, Protein Kinases, Proteins, Proto-Oncogene Proteins, Serine, Protein Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases, Drosophila Proteins, RNA Interference, Cell Line, Tumor, Immunoprecipitation, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-akt, Hydrophobic and Hydrophilic Interactions, TOR Serine-Threonine Kinases, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review